Remdesivir Treatment for COVID 19 in Pregnant Patients with Moderate to Severe Symptoms: Serial Case Report

被引:9
|
作者
Saroyo, Yudianto Budi [1 ]
Rumondang, Amanda [2 ]
Febriana, Irene Sinta [2 ]
Harzif, Achmad Kemal [3 ]
Irwinda, Rima [1 ]
机构
[1] Cipto Mangunkusumo Gen Hosp, Div Maternal Fetal Med, Obstet Gynecol Dept, Jakarta 10430, Indonesia
[2] Cipto Mangunkusumo Gen Hosp, Obstet Gynecol Dept, Jakarta 10430, Indonesia
[3] Cipto Mangunkusumo Gen Hosp, Obstet Gynecol Dept, Reprod Endocrinol & Infertil Div, Jakarta 10430, Indonesia
关键词
Remdesivir; pregnancy; COVID-19; moderate-severe symptoms;
D O I
10.3390/idr13020042
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) infection that causes novel Coronavirus Disease 2019 (COVID-19) has become a major health problem worldwide and been declared a pandemic since March 2020 by WHO. One special population that poses a challenge is pregnant women with COVID-19. There have not been many studies related to COVID-19 in pregnancy. In this study, we present five serial cases of Remdesivir treatment for COVID-19 in pregnant women with moderate to severe symptoms. Case Illustration: We briefly describe five serial cases being treated with Remdesivir therapy during hospitalization. Four cases were delivered by cesarean section, and one was delivered vaginally in gestation week 37. All cases showed a shortened duration of hospitalization, rapid improvement in clinical symptoms, and no adverse events were observed in mothers, fetuses, and neonates. Discussion: Remdesivir, an inhibitor RNA Polymerase, has been used in COVID-19 treatment and is known to shorten recovery time in nonpregnant women. Some studies have shown no adverse effects on Remdesivir for pregnant women. Based on randomized control trial (RCT) during the Ebola epidemic, Remdesivir was safe to use for pregnant women. All cases showed reduced hospitalization time and better clinical outcomes without maternal, fetal, or neonatal adverse events. Conclusion: Remdesivir protocol for pregnant women with moderate to severe symptoms of COVID-19 has resulted in better clinical improvement with a shorter recovery period and no adverse effects during the hospitalization period. Further studies and RCT are warranted to evaluate the biosafety and effects of Remdesivir in pregnant women.
引用
收藏
页码:437 / 443
页数:7
相关论文
共 50 条
  • [21] Compassionate Use of Remdesivir for Patients with Severe Covid-19
    Grein, J.
    Ohmagari, N.
    Shin, D.
    Diaz, G.
    Asperges, E.
    Castagna, A.
    Feldt, T.
    Green, G.
    Green, M. L.
    Lescure, F-X
    Nicastri, E.
    Oda, R.
    Yo, K.
    Quiros-Roldan, E.
    Studemeister, A.
    Redinski, J.
    Ahmed, S.
    Bernett, J.
    Chelliah, D.
    Chen, D.
    Chihara, S.
    Cohen, S. H.
    Cunningham, J.
    Monforte, A. DArminio
    Ismail, S.
    Kato, H.
    Lapadula, G.
    L'Her, E.
    Maeno, T.
    Majumder, S.
    Massari, M.
    Mora-Rillo, M.
    Mutoh, Y.
    Nguyen, D.
    Verweij, E.
    Zoufaly, A.
    Osinusi, A. O.
    DeZure, A.
    Zhao, Y.
    Zhong, L.
    Chokkalingam, A.
    Elboudwarej, E.
    Telep, L.
    Timbs, L.
    Henne, I
    Sellers, S.
    Cao, H.
    Tan, S. K.
    Winterbourne, L.
    Desai, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (24): : 2327 - 2336
  • [22] Placental pathology in a pregnant woman with severe COVID-19 and successful ECMO treatment: a case report
    Anna Rosner-Tenerowicz
    Tomasz Fuchs
    Aleksandra Zimmer-Stelmach
    Michał Pomorski
    Martyna Trzeszcz
    Jacek Zwierzchowski
    Mariusz Zimmer
    [J]. BMC Pregnancy and Childbirth, 21
  • [23] Placental pathology in a pregnant woman with severe COVID-19 and successful ECMO treatment: a case report
    Rosner-Tenerowicz, Anna
    Fuchs, Tomasz
    Zimmer-Stelmach, Aleksandra
    Pomorski, Michal
    Trzeszcz, Martyna
    Zwierzchowski, Jacek
    Zimmer, Mariusz
    [J]. BMC PREGNANCY AND CHILDBIRTH, 2021, 21 (01)
  • [24] REMDESIVIR FOR MODERATE-TO-SEVERE COVID-19 PNEUMONIA IN MAINTENANCE DIALYSIS PATIENTS: A RETROSPECTIVE COHORT STUDY
    Gutierrez, Stephanie
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I691 - I692
  • [25] Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis
    Geffin, Ryan
    Raheem, Shazia
    Pandit, Lavannya M.
    Hunter, Andrew S.
    Holliday Jr, Michael W.
    Rao, Aditya V.
    Shah, Maulin K.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2023, 11
  • [26] Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report
    Jacobson, Jennifer
    Antony, Kathleen
    Beninati, Michael
    Alward, William
    Hoppe, Kara K.
    [J]. CASE REPORTS IN WOMENS HEALTH, 2021, 29
  • [27] Remdesivir for the Treatment of Covid-19-Preliminary Report REPLY
    Beigel, John H.
    Tomashek, Kay M.
    Dodd, Lori E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (10): : 994 - 994
  • [28] Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
    Goldman, Jason D.
    Lye, David C. B.
    Hui, David S.
    Marks, Kristen M.
    Bruno, Raffaele
    Montejano, Rocio
    Spinner, Christoph D.
    Galli, Massimo
    Ahn, Mi-Young
    Nahass, Ronald G.
    Chen, Yao-Shen
    SenGupta, Devi
    Hyland, Robert H.
    Osinusi, Anu O.
    Cao, Huyen
    Blair, Christiana
    Wei, Xuelian
    Gaggar, Anuj
    Brainard, Diana M.
    Towner, William J.
    Munoz, Jose
    Mullane, Kathleen M.
    Marty, Francisco M.
    Tashima, Karen T.
    Diaz, George
    Subramanian, Aruna
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (19): : 1827 - 1837
  • [29] Remdesivir in a pregnant patient with COVID-19 pneumonia
    Dande, Ranadheer
    Qureshi, Anum
    Persaud, Kia
    Puri, Chahat
    Zulfiqar, Sajida
    Awasthi, Shankar
    [J]. JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2021, 11 (01): : 103 - 106
  • [30] Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score
    Sellers, Jacob
    Chang, Jongwha
    Jones, Jessica
    Hintze, Trager D.
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 78